SULFASALAZINE INDUCED AGRANULOCYTOSIS TREATED WITH GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR

EJ KUIPERS; E VELLENGA; JTM DEWOLF; BPC HAZENBERG

SULFASALAZINE INDUCED AGRANULOCYTOSIS TREATED WITH GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR

EJ KUIPERS, E VELLENGA, JTM DEWOLF, BPC HAZENBERG

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

Abstract

We report the use of granulocyte-macrophage colony stimulating factor (GM-CSF) in a case of rheumatoid arthritis with sulfasalazine induced agranulocytosis, leading to a rapid bone marrow recovery within 7 days. This case and 2 others reported in the literature emphasize the need for further research into the possible role of GM-CSF in the treatment of drug induced agranulocytosis.

Original language	English
Pages (from-to)	621-622
Number of pages	2
Journal	Journal of Rheumatology
Volume	19
Issue number	4
Publication status	Published - Apr-1992

Keywords

RHEUMATOID ARTHRITIS
SULFASALAZINE
AGRANULOCYTOSIS
GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR
RHEUMATOID-ARTHRITIS
SULPHASALAZINE
TOXICITY

Cite this

@article{d879fcfb20324b3f99e40b1ce66af0b0,

title = "SULFASALAZINE INDUCED AGRANULOCYTOSIS TREATED WITH GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR",

abstract = "We report the use of granulocyte-macrophage colony stimulating factor (GM-CSF) in a case of rheumatoid arthritis with sulfasalazine induced agranulocytosis, leading to a rapid bone marrow recovery within 7 days. This case and 2 others reported in the literature emphasize the need for further research into the possible role of GM-CSF in the treatment of drug induced agranulocytosis.",

keywords = "RHEUMATOID ARTHRITIS, SULFASALAZINE, AGRANULOCYTOSIS, GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR, RHEUMATOID-ARTHRITIS, SULPHASALAZINE, TOXICITY",

author = "EJ KUIPERS and E VELLENGA and JTM DEWOLF and BPC HAZENBERG",

year = "1992",

month = apr,

language = "English",

volume = "19",

pages = "621--622",

journal = "The Journal of Rheumatology",

issn = "0315-162X",

publisher = "J RHEUMATOL PUBL CO",

number = "4",

}

TY - JOUR

T1 - SULFASALAZINE INDUCED AGRANULOCYTOSIS TREATED WITH GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR

AU - KUIPERS, EJ

AU - VELLENGA, E

AU - DEWOLF, JTM

AU - HAZENBERG, BPC

PY - 1992/4

Y1 - 1992/4

N2 - We report the use of granulocyte-macrophage colony stimulating factor (GM-CSF) in a case of rheumatoid arthritis with sulfasalazine induced agranulocytosis, leading to a rapid bone marrow recovery within 7 days. This case and 2 others reported in the literature emphasize the need for further research into the possible role of GM-CSF in the treatment of drug induced agranulocytosis.

AB - We report the use of granulocyte-macrophage colony stimulating factor (GM-CSF) in a case of rheumatoid arthritis with sulfasalazine induced agranulocytosis, leading to a rapid bone marrow recovery within 7 days. This case and 2 others reported in the literature emphasize the need for further research into the possible role of GM-CSF in the treatment of drug induced agranulocytosis.

KW - RHEUMATOID ARTHRITIS

KW - SULFASALAZINE

KW - AGRANULOCYTOSIS

KW - GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR

KW - RHEUMATOID-ARTHRITIS

KW - SULPHASALAZINE

KW - TOXICITY

M3 - Article

VL - 19

SP - 621

EP - 622

JO - The Journal of Rheumatology

JF - The Journal of Rheumatology

SN - 0315-162X

IS - 4

ER -